Clinical Trials Directory

Trials / Completed

CompletedNCT03609333

Characterizing the cerebrovAscular Physiology of Optimal Mean Arterial Pressure Targeted Resuscitation

Characterizing the cerebrovAscular Physiology of Optimal Mean Arterial Pressure Targeted Resuscitation in Hypoxic Ischemic Brain Injury After Cardiac Arrest

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypoxic ischemic brain injury is a devastating illness that occurs after cardiac arrest (the heart stopping) and can yield irreversible brain damage, often leading to death. The mainstay in therapy is to optimize the delivery of oxygen to the brain to help it recover. In patients with traumatic brain injury (similar to HIBI), the investigators are able to optimize oxygen delivery to the brain with the use of wires placed into the brain that sense the pressure and oxygen in the skull to find the ideal blood pressure for each individual patient. This strategy is associated with improved outcomes. The investigators are conducting a prospective study investigating whether the perfusion within proximity to the optimal MAP is associated with improved brain oxygenation and blood flow .

Conditions

Interventions

TypeNameDescription
DEVICEMultimodal NeuromonitoringApplication of multimodal neuromonitoring

Timeline

Start date
2016-11-12
Primary completion
2020-06-30
Completion
2020-06-30
First posted
2018-08-01
Last updated
2020-11-03

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03609333. Inclusion in this directory is not an endorsement.